Filing Details

Accession Number:
0001299130-21-000087
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-24 20:50:00
Reporting Period:
2021-02-22
Accepted Time:
2021-02-24 20:50:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1299130 Pacific Biosciences Of California Inc. PACB Laboratory Analytical Instruments (3826) 161590339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1317102 Michael Hunkapiller Pacific Biosciences Of California, Inc.
1305 O'Brien Drive
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-22 45,689 $6.14 894,094 No 4 M Direct
Common Stock Acquisiton 2021-02-22 45,890 $5.72 939,984 No 4 M Direct
Common Stock Acquisiton 2021-02-22 45,967 $7.87 985,951 No 4 M Direct
Common Stock Acquisiton 2021-02-22 45,686 $5.27 1,031,637 No 4 M Direct
Common Stock Acquisiton 2021-02-22 45,895 $2.63 1,077,532 No 4 M Direct
Common Stock Disposition 2021-02-22 57,260 $37.17 1,020,272 No 4 S Direct
Common Stock Disposition 2021-02-22 33,491 $38.08 986,781 No 4 S Direct
Common Stock Disposition 2021-02-22 38,360 $39.15 948,421 No 4 S Direct
Common Stock Disposition 2021-02-22 57,902 $40.28 890,519 No 4 S Direct
Common Stock Disposition 2021-02-22 42,114 $41.06 848,405 No 4 S Direct
Common Stock Acquisiton 2021-02-23 86,084 $6.14 934,489 No 4 M Direct
Common Stock Acquisiton 2021-02-23 86,065 $5.72 1,020,554 No 4 M Direct
Common Stock Acquisiton 2021-02-23 86,022 $7.87 1,106,576 No 4 M Direct
Common Stock Acquisiton 2021-02-23 86,047 $5.27 1,192,623 No 4 M Direct
Common Stock Acquisiton 2021-02-23 29,103 $2.63 1,221,726 No 4 M Direct
Common Stock Disposition 2021-02-23 24,100 $30.90 1,197,626 No 4 S Direct
Common Stock Disposition 2021-02-23 28,595 $31.71 1,169,031 No 4 S Direct
Common Stock Disposition 2021-02-23 18,259 $32.98 1,150,772 No 4 S Direct
Common Stock Disposition 2021-02-23 42,378 $34.22 1,108,394 No 4 S Direct
Common Stock Disposition 2021-02-23 113,308 $35.10 995,086 No 4 S Direct
Common Stock Disposition 2021-02-23 74,119 $35.99 920,967 No 4 S Direct
Common Stock Disposition 2021-02-23 72,562 $36.85 848,405 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-02-22 45,689 $0.00 45,689 $6.14
Common Stock Stock Option (right to buy) Disposition 2021-02-22 45,890 $0.00 45,890 $5.72
Common Stock Stock Option (right to buy) Disposition 2021-02-22 45,967 $0.00 45,967 $7.87
Common Stock Stock Option (right to buy) Disposition 2021-02-22 45,686 $0.00 45,686 $5.27
Common Stock Stock Option (right to buy) Disposition 2021-02-22 45,895 $0.00 45,895 $2.63
Common Stock Stock Option (right to buy) Disposition 2021-02-23 86,084 $0.00 86,084 $6.14
Common Stock Stock Option (right to buy) Disposition 2021-02-23 86,065 $0.00 86,065 $5.72
Common Stock Stock Option (right to buy) Disposition 2021-02-23 86,022 $0.00 86,022 $7.87
Common Stock Stock Option (right to buy) Disposition 2021-02-23 86,047 $0.00 86,047 $5.27
Common Stock Stock Option (right to buy) Disposition 2021-02-23 29,103 $0.00 29,103 $2.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
121,811 2024-03-17 No 4 M Direct
354,110 2025-03-16 No 4 M Direct
354,033 2026-03-15 No 4 M Direct
354,314 2027-02-15 No 4 M Direct
54,105 2028-03-15 No 4 M Direct
35,727 2024-03-17 No 4 M Direct
268,045 2025-03-16 No 4 M Direct
268,011 2026-03-15 No 4 M Direct
268,267 2027-02-15 No 4 M Direct
25,002 2028-03-15 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.
  2. This sale price represents the weighted average sale price of the shares sold ranging from $36.65 to $37.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  3. This sale price represents the weighted average sale price of the shares sold ranging from $37.65 to $38.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. This sale price represents the weighted average sale price of the shares sold ranging from $38.67 to $39.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  5. This sale price represents the weighted average sale price of the shares sold ranging from $39.67 to $40.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  6. This sale price represents the weighted average sale price of the shares sold ranging from $40.67 to $41.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  7. This sale price represents the weighted average sale price of the shares sold ranging from $30.37 to $31.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  8. This sale price represents the weighted average sale price of the shares sold ranging from $31.38 to $32.34 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  9. This sale price represents the weighted average sale price of the shares sold ranging from $32.41 to $33.39 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  10. This sale price represents the weighted average sale price of the shares sold ranging from $33.57 to $34.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  11. This sale price represents the weighted average sale price of the shares sold ranging from $34.57 to $35.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  12. This sale price represents the weighted average sale price of the shares sold ranging from $35.57 to $36.54 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  13. This sale price represents the weighted average sale price of the shares sold ranging from $36.57 to $37.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  14. The shares subject to the option are fully vested and exercisable.
  15. The shares subject to the option vest in equal monthly installments over a four year period, provided that the Reporting Person continues to serve through each vesting date.